Hello, everyone-
I've received numerous emails and thought I'd just post to the group so we are all clear. The study for women who are on herceptin is for stage IV disease patients only, in remission. The main criteria for eligibility beyond this is that you be HLA A2. This is determined with a blood test, and is necessary as the vaccine targets this site on the HER2 molecule. If you are not A2 then this strategy will not benefit you. Our website address for more info is:
www.tumorvaccinegroup.org
Please let me know if you have other questions!
Hybrid Mode
